Alexion Pharmaceuticals has announced changes to its executive leadership team:
* Brian Goff is joining Alexion as Chief Commercial Officer. He succeeds Carsten Thiel who is leaving the Company to pursue new opportunities.
* Dave Anderson, Chief Financial Officer, will resign his position at the end of August. A search for a new CFO is underway.
* Martin Mackay, Executive Vice President, Head of Research & Development will be retiring from Alexion at the end of 2017. A search is also underway for a new Head of R&D.
* Clare Carmichael, Executive Vice President, Chief Human Resources Officer, will be leaving the Company to pursue new opportunities. Recruiting is underway for a new Head of Human Resources.